Key statistics
As of last trade, AIM ImmunoTech Inc (AIM:ASQ) traded at 1.19, 59.78% above the 52 week low of 0.7416 set on Feb 09, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.14 |
|---|---|
| High | 1.22 |
| Low | 1.12 |
| Bid | 1.17 |
| Offer | 1.20 |
| Previous close | 1.15 |
| Average volume | 8.80m |
|---|---|
| Shares outstanding | 2.86m |
| Free float | 2.75m |
| P/E (TTM) | -- |
| Market cap | 3.28m USD |
| EPS (TTM) | -19.82 USD |
Data delayed at least 15 minutes, as of Feb 18 2026 15:50 GMT.
More ▼
Announcements
- CORRECTION: AIM ImmunoTech Announces Commencement of Rights Offering
- AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event
- AIM ImmunoTech Announces Commencement of Rights Offering
- AIM ImmunoTech to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
- AIM ImmunoTech Reports Positive Year-End Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer
- AIM ImmunoTech Announces Changes to Key Dates and Terms Related to Announced Rights Offering
- AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering
- AIM ImmunoTech Announces Stock Dividend
- AIM ImmunoTech Announces Release of the Next CEO Corner Segment
- AIM ImmunoTech to Participate in Live ‘Fireside’ Chat on Virtual Investor Closing Bell Series
More ▼
